Friday, March 04, 2005

Tysabri (Natalizumab): An Additional Case

Rare Infection Is Confirmed in 2nd Patient on M.S. Drug
By ANDREW POLLACK
The New York Times
Published: March 4, 2005

The makers of the multiple sclerosis drug Tysabri said yesterday that a second patient who used the drug had been confirmed to be suffering from a rare but deadly brain infection. The confirmed diagnosis is likely to somewhat diminish the chances that the drug will be able to return to the market.

[ ... Read the full article ... ]

0 Comments:

Post a Comment

<< Home